- Home
- Life Sciences
- Pharmaceutical
- Pathology
- Pathology Analysis & Statistics, February 2013 (p4)
Talk to Robyn
00 1 718 213 49 04
Search inside this page
Top countries
- United States (3 976)
- World (47 572)
- Japan (2 645)
- France (2 556)
- Germany (2 547)
-
- Spain (2 531)
- United Kingdom (2 513)
- Europe (559)
- Italy (2 542)
- China (2 441)
- India (2 398)
- Canada (2 196)
- Australia (2 157)
- Sweden (2 019)
- Denmark (2 010)
- South Korea (2 355)
- Norway (2 006)
- Singapore (2 167)
- Switzerland (2 053)
- Indonesia (2 294)
Publication dates
Publishers
- Global Data (1 538)
- Global Markets Direct (1 838)
- Bioseeker (243)
- Euromonitor International (26)
- BCC Research (41)
-
- Ibisworld (8)
- Daedal Research (2)
- Firstword Pharma (7)
- GBI Research (41)
- KnowMade (2)
- World Market Intelligence Ltd (18)
- Asianet-Pakistan (4)
- Currentpartnering (97)
- Global Industry Analysts (1)
- International Market Analysis Research and Consult (11)
- La Merie Publishing (31)
- MarketLine (41)
- Transparency Market Research (1)
- TriMark Publications (7)
- Business Monitor International (401 825)
- Datamonitor (316)
- Life Science Analytics (LSA) (61)
- Global Research & Data Services (55)
- ICD Research (47)
- Frost & Sullivan (44)
- Timely Data Resources Inc. (41)
- Visiongain (32)
- Global Industry Analyst (28)
- Espicom Business Intelligence (27)
- Business Review (23)
- ABMRG (22)
- The Assessment Group (19)
- Kalorama Information (17)
- SCRIP Insights (17)
- Koncept Analytics (15)
- Asia Market Information & Development Company (14)
- CHI Insight Pharma Reports (14)
- Apollo Managed Care Consultants (13)
- Infiniti Research Limited (9)
- Sociable Pharma (9)
- IData Research, Inc. (9)
- Grey House Publishing (7)
- RNCOS (6)
- BioPharm Reports (5)
- MarketsandMarkets (5)
- Venture Planning Group (5)
- Aruvian's R'search (4)
- Freedonia (4)
- Canadean Ltd (3)
- Netscribes (India) Pvt. Ltd. (3)
- Renub Research (3)
- Arrowhead (2)
- France Innovation Scientifique et Transfert (2)
- Greystone Research Associates (2)
- Packaged Facts (2)
- Urch Publishing (2)
- Barnes Reports (1)
- Cygnus Business Consulting and Research (1)
- Ken Research Private (1)
- PMR Ltd. (1)
- Red Mountain Insights (1)
- Research In China (1)
- VacZine Analytics Group Of Assay Advantage Ltd (1)
- Verdict Research Ltd (1)
- WinterGreen Research (1)
- Zzz FACT Research (1)
All regions
-
- Algeria (2 248)
- Angola (2 320)
- Benin (2 312)
- Botswana (2 225)
- Burkina Faso (2 294)
- Burundi (2 306)
- Cameroon (2 318)
- Cape Verde (2 243)
- Central African Republic (106)
- Chad (2 313)
- Comoros (2 099)
- Congo, Democratic Republic Of (2 505)
- Djibouti (2 289)
- Egypt (2 338)
- Equatorial Guinea (2 292)
- Eritrea (2 259)
- Ethiopia (2 297)
- Gabon (2 269)
- Gambia (2 277)
- Ghana (2 321)
- Guinea (6 871)
- Guinea Bissau (2 303)
- Kenya (2 294)
- Lesotho (2 130)
- Liberia (2 210)
- Libyan Arab Jamahiriya (2 235)
- Madagascar (2 268)
- Malawi (2 309)
- Mali (2 318)
- Mauritania (2 262)
- Mauritius (2 206)
- Morocco (2 311)
- Mozambique (2 290)
- Namibia (2 221)
- Niger (2 318)
- Nigeria (2 327)
- Rwanda (2 281)
- Sao Tome and Principe (1 956)
- Senegal (2 315)
- Seychelles (2 063)
- Sierra Leone (2 307)
- Somalia (2 231)
- South Africa (2 267)
- Sudan (2 336)
- Swaziland (2 206)
- Tanzania (2 290)
- Togo (2 309)
- Tunisia (2 237)
- Uganda (2 320)
- Zambia (2 289)
- Zimbabwe (2 288)
-
- Afghanistan (2 321)
- Armenia (2 178)
- Azerbaijan (2 186)
- Bahrain (2 030)
- Bangladesh (2 288)
- Bhutan (2 207)
- Brunei Darussalam (2 078)
- Cambodia (2 300)
- China (2 441)
- Georgia (2 084)
- India (2 398)
- Indonesia (2 294)
- Iran (2 223)
- Iraq (2 315)
- Israel (2 034)
- Japan (2 645)
- Jordan (2 146)
- Kazakhstan (2 118)
- Kuwait (2 116)
- Kyrgyz Republic (kyrgyzstan) (2 187)
- Laos (2 295)
- Lebanon (1 553)
- Malaysia (2 290)
- Maldives (2 199)
- Mongolia (99)
- Myanmar (2 260)
- Nepal (2 280)
- North Korea (119)
- Oman (2 189)
- Pakistan (2 300)
- Philippines (2 300)
- Qatar (2 012)
- Saudi Arabia (2 234)
- Singapore (2 167)
- South Korea (2 355)
- Sri Lanka (2 254)
- Syrian Arab Republic (2 188)
- Taiwan (19)
- Tajikistan (2 163)
- Thailand (2 292)
- Turkey (5)
- Turkmenistan (98)
- United Arab Emirates (2 142)
- Uzbekistan (2 189)
- Vietnam (2 311)
- Yemen (2 334)
-
- Albania (2 040)
- Andorra (1 425)
- Austria (2 030)
- Belarus (2 055)
- Belgium (2 053)
- Bosnia and Herzegovina (2 028)
- Bulgaria (2 053)
- Croatia (2 006)
- Cyprus (1 986)
- Czech Republic (2 008)
- Denmark (2 010)
- Estonia (1 966)
- Finland (1 993)
- France (2 556)
- Germany (2 547)
- Greece (2 087)
- Hungary (2 039)
- Iceland (1 904)
- Ireland (2 032)
- Italy (2 542)
- Latvia (2 017)
- Lithuania (2 087)
- Luxembourg (1 932)
- Macedonia (91)
- Malta (1 990)
- Moldova, Republic Of (2 023)
- Monaco (1 268)
- Netherlands (2 052)
- Norway (2 006)
- Poland (2 080)
- Portugal (2 110)
- Romania (2 068)
- Russian Federation (2 148)
- San Marino (1 114)
- Serbia and Montenegro (2 060)
- Slovakia (slovak Republic) (2 045)
- Slovenia (1 978)
- Spain (2 531)
- Sweden (2 019)
- Switzerland (2 053)
- Ukraine (2 096)
- United Kingdom (2 513)
-
- Antigua and Barbuda (2 061)
- Bahamas (2 105)
- Barbados (2 101)
- Belize (2 122)
- Canada (2 196)
- Costa Rica (2 185)
- Cuba (2 211)
- Dominica (4 113)
- Dominican Republic (2 285)
- El Salvador (2 220)
- Grenada (2 018)
- Guatemala (2 373)
- Haiti (2 275)
- Honduras (2 317)
- Jamaica (2 169)
- Mexico (2 379)
- Nicaragua (2 265)
- Panama (1 561)
- Saint Kitts & Nevis (1 889)
- Saint Lucia (2 227)
- United States (3 976)
-
- Argentina (2 263)
- Australia (2 157)
- Brazil (2 439)
- Canada (2 196)
- China (2 441)
- France (2 556)
- Germany (2 547)
- India (2 398)
- Indonesia (2 294)
- Italy (2 542)
- Japan (2 645)
- Mexico (2 379)
- Russian Federation (2 148)
- Saudi Arabia (2 234)
- South Africa (2 267)
- South Korea (2 355)
- Turkey (5)
- United Kingdom (2 513)
- United States (3 976)
-
- Australia (2 157)
- Austria (2 030)
- Belgium (2 053)
- Canada (2 196)
- Chile (2 214)
- Czech Republic (2 008)
- Denmark (2 010)
- Estonia (1 966)
- Finland (1 993)
- France (2 556)
- Germany (2 547)
- Greece (2 087)
- Hungary (2 039)
- Iceland (1 904)
- Ireland (2 032)
- Israel (2 034)
- Italy (2 542)
- Japan (2 645)
- Luxembourg (1 932)
- Mexico (2 379)
- Netherlands (2 052)
- New Zealand (1 942)
- Norway (2 006)
- Poland (2 080)
- Portugal (2 110)
- Slovenia (1 978)
- South Korea (2 355)
- Spain (2 531)
- Sweden (2 019)
- Switzerland (2 053)
- Turkey (5)
- United Kingdom (2 513)
- United States (3 976)
data types
Free Market Research Guides to Download
Pathology Analysis & Statistics, February 2013 (p4)
You might be interested in: cancer, breast cancer, prostate cancer, more »
» Purchase Premium Reports
91-130 of about 4 900 reports
Brivaracetam (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
Brivaracetam (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Brivaracetam (Epilepsy) - Forecast and Market Analysis to 2022?. ...
- Industries : Pathology
- Countries : Spain, Italy, France, Germany, United States, World, Europe, United Kingdom
Ganaxolone (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
Ganaxolone (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Ganaxolone (Epilepsy) - Forecast and Market Analysis to 2022?. ...
- Industries : Pathology
- Countries : Spain, Italy, France, Germany, United States, World, Europe, United Kingdom
Vimpat (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
Vimpat (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Vimpat (Epilepsy) - Forecast and Market Analysis to 2022?. Epilepsy ...
- Industries : Pathology
- Countries : United States, Spain, Italy, France, Germany, Japan, India, World, Europe, United Kingdom
Fycompa (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
Fycompa (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Fycompa (Epilepsy) - Forecast and Market Analysis to 2022?. Epilepsy ...
- Industries : Pathology
- Countries : Japan, United States, Spain, Italy, France, Germany, World, Europe, United Kingdom
VX-765 (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
VX-765 (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?VX-765 (Epilepsy) - Forecast and Market Analysis to 2022?. Epilepsy ...
- Industries : Pathology
- Countries : Spain, Italy, France, Germany, United States, World, Europe, United Kingdom
Zebinix (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
Zebinix (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Zebinix (Epilepsy) - Forecast and Market Analysis to 2022?. Epilepsy ...
- Industries : Pathology
- Countries : United States, Spain, Italy, France, Germany, India, World, Europe, United Kingdom
Banzel / Inovelon (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
Banzel / Inovelon (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Banzel / Inovelon (Epilepsy) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : World, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Zonegran (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
Zonegran (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Zonegran (Epilepsy) - Forecast and Market Analysis to 2022?. Epilepsy ...
- Industries : Pathology
- Countries : Japan, United States, World, Spain, Italy, France, Germany, India, Europe, United Kingdom, China
Trobalt/Potiga (Epilepsy) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- February 2013
- by Global Data
Trobalt/Potiga (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Trobalt/Potiga (Epilepsy) - Forecast and Market Analysis ...
- Industries : Pathology
- Countries : United States
Hemoglobin A1c Testing Markets
- $ 3 400
- Industry report
- March 2013
- by TriMark Publications
Hemoglobin A1c (HbA1c) testing is the most recent major technology to have entered the diabetes testing market. As the global prevalence of diabetes mellitus continues to increase rapidly, with more than ...
- Industries : Pathology
- Countries : United States, World
PharmaPoint: Epilepsy - Current and Future Players
- $ 2 995
- Industry report
- February 2013
- by Global Data
PharmaPoint: Epilepsy - Current and Future Players Summary GlobalData has released its pharma report, ?PharmaPoint: Epilepsy - Current and Future Players?. The report is a vital source of up-to-date ...
- Industries : Pathology
- Countries : World
PharmaPoint: Osteoporosis - Current and Future Players
- $ 2 995
- Industry report
- February 2013
- by Global Data
PharmaPoint: Osteoporosis - Current and Future Players Summary Osteoporosis is caused by the gradual weakening of the bones due to abnormal osteocyte function, which occurs as a result of hormonal fluctuations, ...
- Industries : Pathology
- Countries : World
PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players
- $ 2 995
- Industry report
- May 2013
- by Global Data
PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players Summary GlobalData has released its pharma report, ?PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players?. ...
- Industries : Pathology
- Countries : World
PharmaPoint: Multiple Sclerosis - Current and Future Players
- $ 2 995
- Industry report
- March 2013
- by Global Data
PharmaPoint: Multiple Sclerosis - Current and Future Players Summary GlobalData has released its pharma report, ?PharmaPoint: Multiple Sclerosis - Current and Future Players?. The report is a vital source ...
- Industries : Pathology
- Countries : World
Therapy in United States: Type 2 Diabetes - Pipeline Review, H1 2012
- $ 2 500
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Type 2 Diabetes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- February 2013
- by Global Data
Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, ...
- Industries : Pathology
- Countries : World
Pathology Industry: Non-Small Cell Lung Cancer - Pipeline Review, H1 2012
- $ 2 500
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Non-Small Cell Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...
- Industries : Pathology
- Countries : United States, World
Rheumatoid Arthritis - Pipeline Review, H1 2013
- $ 2 500
- Company report
- March 2013
- by Global Markets Direct
Rheumatoid Arthritis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Rheumatoid Arthritis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This ...
- Industries : Pathology
Drug and Medication Industry: Prostate Cancer - Pipeline Review, H1 2012
- $ 2 500
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Prostate Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Pathology
- Countries : United States
Drug and Medication Industry: Ovarian Cancer - Pipeline Review, H1 2012
- $ 2 500
- Company report
- April 2013
- by Global Markets Direct
This report provides information on the therapeutic development for Ovarian Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : United States
Pathology in United States: Breast Cancer - Pipeline Review, H1 2012
- $ 2 500
- Company report
- April 2013
- by Global Markets Direct
This report provides information on the therapeutic development for Breast Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2013
- $ 2 500
- Industry report
- March 2013
- by Global Data
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials ...
- Industries : Pathology
- Countries : World, United States
World Pathology: Metastatic Lung Cancer - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Metastatic Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World, United States, Canada
World Pathology: Interstitial Cystitis (Painful Bladder Syndrome) ? Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome), complete with latest updates, and special features on late-stage and discontinued projects. ...
- Industries : Pathology
- Countries : World
World Pathology: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) ? Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), complete with latest updates, and special features on late-stage and ...
- Industries : Pathology
- Countries : World
World Pathology: Chronic Plaque Psoriasis - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Chronic Plaque Psoriasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : World
Pathology in United States: Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Cutaneous T-Cell Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Pathology
- Countries : United States
Pathology in United States: Post-Traumatic Stress Disorder (PTSD) ? Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Post-Traumatic Stress Disorder (PTSD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...
- Industries : Pathology
- Countries : United States, World
World Pathology: Waldenstrom Macroglobulinemia - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Waldenstrom Macroglobulinemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...
- Industries : Pathology
- Countries : United States, World
Therapy in United States: Post Menopausal Osteoporosis - Pipeline Review, H1 2012
- $ 2 000
- Company report
- April 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Post Menopausal Osteoporosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...
- Industries : Pathology
- Countries : World
Norway Peptic Ulcer Disease, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Norway
Austria Peptic Ulcer Disease, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Austria
Iraq Prostate Cancer, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Iraq, World
Lesotho Post-traumatic Stress Disorder, 15-29 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Lesotho
Palau Post-traumatic Stress Disorder, 45-59 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : World
Honduras Prostate Cancer, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Honduras
Papua New Guinea Schistosomiasis, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Papua New Guinea, Guinea
Paraguay Prostate Cancer, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Paraguay
Dominican Republic Post-traumatic Stress Disorder, 30-44 Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Dominican Republic, Dominica
Belgium Protein-energy Malnutrition, 70+ Yrs, Male, Dalys
- $ 250
- Industry data
- May 2013
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
- Industries : Pathology
- Countries : Belgium
» Download Public Reports
About 17 000 reports
Company Report: Pathology in The United States and Ireland for Year 2013
- Company report
- May 2013
- 5 pages
- by Corporation
... Involved, even indirectly, with an important therapeutic area that addresses the needs of millions of patients who suffer from respiratory disease is particularly meaningful to all of us at elan." Relvar ...
Pharmaceutical Business Analysis
May 2013U.s. Pharmaceutical Industry
May 2013The Swazi Pharmaceutical Industry
May 2013» Read our Company Profiles
About 200 CompaniesGlaxoSmithKline P.L.C.
United StatesNovartis Inc.
SwitzerlandGlaxoSmithKline PLC
United KingdomEli Lilly and Co.
United StatesLilly and Co.
United StatesReportlinker.com © Copyright 2013. All rights reserved.
